Increase in awareness and acceptance of personalized medicines to drive the growth of global therapeutic drug monitoring market
According to TechSci Research,“Global Therapeutic Drug Monitoring Market By Technology(Immunoassays, Proteomic Technologies), By Drug Class(Antiarrhythmic Drugs, Immunosuppressants, Antiepileptic Drugs, Others), By Active Ingredient (Amikacin, Caffeine, Carbamazepine, Cyclosporine, Digitoxin, Digoxin, Disopyramide, Ethosuxamide, Gentamicin, Lidocaine, Lithium, Methotrexate, NAPA, Phenobarbital, Quinidine, Sirolimus, Tacrolimus, Vancomycin, Others), By End-User (Hospitals, Diagnostic Centres, Others), By Product (Immunoassay Equipment, Reagents, Other Consumables), By Region, Forecast & Opportunities, 2025”, the global therapeutic drug monitoring market is expected to grow at a steady CAGR rate during the forecast period on account of growing demand for genetic testing. It’s a practice of measuring drug amount in bloodstream to maintain its effective concentration. It is used to identify therapeutic failure, avoid toxicity and adverse drug reactions. The reasons for growth of therapeutic drug monitoring include growing demand for personalized medicines and advanced technologies. Therapeutic drug monitoring is generally used for anti-cancer drug, organ transplant procedures, and advanced treatment therapies such as gene testing and proteomics. Increasing microbial resistance is another factor which has stressed on the manufacturing of personalized medicine and therapeutic drug monitoring market. There has been advances in the field of biomedical technology such as nano biosensors. Advancement in tools like spectrometry, assay kits, alternative matrices are the main factors responsible for growth of therapeutic drug monitoring market.